Dutia Suren G 4
4 · Citius Pharmaceuticals, Inc. · Filed Sep 6, 2018
Insider Transaction Report
Form 4
Dutia Suren G
Director
Transactions
- Award
Options to Purchase Common Stock
2018-09-04+15,000→ 15,000 totalExercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying)
Holdings
- 26,667
Options to Purchase Common Stock
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.
- [F2]The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018.
- [F3]The option granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.